Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Tejwani · SciRah

Researcher profile · Semantic Scholar

S. Tejwani

Share profile

S. Tejwani — researcher profile on SciRah

h-index: 13
Works: 30
Citations: 2,101

Most-cited papers

Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500.
J. Smerage, W. Barlow, G. Hortobagyi, E. Winer +10 more
2014Journal of Clinical Oncology609 citations Open access
Semantic Scholar
Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study.
S. Slovin, C. Higano, O. Hamid, S. Tejwani +7 more
2013Annals of Oncology554 citations Open access
Semantic Scholar
Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205
M. Dhodapkar, M. Sznol, Biwei Zhao, Ding Wang +15 more
2014Science Translational Medicine354 citations Open access
Semantic Scholar
Androgen receptor and E2F-1 targeted thymoquinone therapy for hormone-refractory prostate cancer.
A. Kaseb, K. Chinnakannu, Di Chen, Arun Sivanandam +4 more
2007Cancer Research216 citations Open access
Semantic Scholar
Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy.
L. Rogers, Sandra Remer, S. Tejwani
2004Neuro-Oncology65 citations Open access
Semantic Scholar
Phase I trial of ipilimumab (IPI) alone and in combination with radiotherapy (XRT) in patients with metastatic castration resistant prostate cancer (mCRPC)
T. Beer, S. Slovin, C. Higano, S. Tejwani +3 more
200862 citations
Semantic Scholar
Initial phase II experience of ipilimumab (IPI) alone and in combination with radiotherapy (XRT) in patients with metastatic castration-resistant prostate cancer (mCRPC).
S. Slovin, T. Beer, C. Higano, S. Tejwani +6 more
2009Journal of Clinical Oncology54 citations
Semantic Scholar
Androgen regulated TRPM8 expression: a potential mRNA marker for metastatic prostate cancer detection in body fluids.
V. U. Bai, Shalini Murthy, K. Chinnakannu, F. Muhletaler +5 more
2009International Journal of Oncology43 citations Open access
Semantic Scholar
Clinical Efficacy of Enzalutamide vs Bicalutamide Combined With Androgen Deprivation Therapy in Men With Metastatic Hormone-Sensitive Prostate Cancer
U. Vaishampayan, L. Heilbrun, P. Monk, S. Tejwani +11 more
2021JAMA Network Open41 citations Open access
Semantic Scholar
Identification of prostate cancer mRNA markers by averaged differential expression and their detection in biopsies, blood, and urine
V. U. Bai, A. Kaseb, S. Tejwani, G. Divine +4 more
2007Proceedings of the National Academy of Sciences of the United States of America32 citations Open access
Semantic Scholar
Pilot Phase II Trial of Bevacizumab Monotherapy in Nonmetastatic Castrate-Resistant Prostate Cancer
S. Ogita, S. Tejwani, L. Heilbrun, J. Fontana +5 more
2012ISRN Oncology18 citations Open access
Semantic Scholar
Abstract S5-07: SWOG S0500 – A randomized phase III trial to test the strategy of changing therapy versus maintaining therapy for metastatic breast cancer patients who have elevated circulating tumor cell (CTC) levels at first follow-up assessment
J. Smerage, W. Barlow, D. Hayes, E. Winer +9 more
201317 citations
Semantic Scholar
Ipilimumab (IPI) in metastatic castrate-resistant prostate cancer (mCRPC): Results from an open-label, multicenter phase I/II study.
S. Slovin, O. Hamid, S. Tejwani, C. Higano +7 more
2012Journal of Clinical Oncology15 citations
Semantic Scholar
Genomic profiling of circulating tumour DNA (ctDNA) and tumour tissue for the evaluation of rucaparib in metastatic castration-resistant prostate cancer (mCRPC).
S. Chowdhury, R. McDermott, J. Piulats, J. Shapiro +16 more
2018Annals of Oncology5 citations Open access
Semantic Scholar
Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study
M. Wagner, C. Hennessy, A. Beeghly, B. French +43 more
2022Cancers4 citations Open access
Semantic Scholar
Ischemic myositis in a diabetic patient receiving chemotherapy
M. Vatca, S. Tejwani, T. Yates
20094 citations
Semantic Scholar
Randomized trial of enzalutamide versus bicalutamide in combination with androgen deprivation in metastatic hormone sensitive prostate cancer: A Prostate Cancer Clinical Trials Consortium trial.
U. Vaishampayan, L. Heilbrun, P. Monk, S. Tejwani +8 more
20182 citations
Semantic Scholar
SAPHO Syndrome Masquerading as Metastatic Breast Cancer
Devin Malik, R. Handa, Andrew M. Petraszko, S. Tejwani
2018Case Reports in Rheumatology2 citations Open access
Semantic Scholar
A Case of Immune-Mediated Pneumonitis Associated With Dual Nivolumab and Ipilimumab Immunotherapy Treatment
Tala Al-Saghir, Noor M Suleiman, Benjamin D. Goodman, Michael W. Ferguson +1 more
2023Cureus1 citations Open access
Semantic Scholar
Dhodapkar NY-ESO-1 to the Dendritic Cell Receptor DEC-205 Induction of Antigen-Specific Immunity with a Vaccine Targeting
M. Dhodapkar, M. Sznol, Biwei Zhao, Ding Wang +15 more
20141 citations
Semantic Scholar
Phase I pharmacokinetic study of dasatinib (BMS-354825) in patients with advanced malignancies and varying levels of liver dysfunction: S0711, a SWOG early therapeutics committee study.
J. Sarantopoulos, A. Hoering, T. Synold, D. Mahalingam +16 more
20121 citations
Semantic Scholar
Cardiotoxicity with fluorouracil and capecitabine revisited
Ajay Tejwani, T. Yates, S. Tejwani
20081 citations
Semantic Scholar
44Overview of tivozanib (tivo) safety in phase 3 clinical trials in patients with metastatic renal cell carcinoma (mRCC)
Pedro C. Barata, Brian Rini, Toni Choueri, S. Pal +16 more
2025The Oncologist0 citations Open access
Semantic Scholar
S3296 First Reported Case of Endoscopic En Bloc Resection of Esophageal Liposarcoma
Taher Jamali, J. Pimentel, K. Perry, Jack Tocco +3 more
2023American Journal of Gastroenterology0 citations
Semantic Scholar
Abstract C120: Are there racial disparities in the incidence of venous thromboembolism (VTE) in hospitalized cancer patients with COVID-19?
A. Khan, Chun-Hui Lin, S. Tejwani
2023Cancer Epidemiology, Biomarkers & Prevention0 citations
Semantic Scholar
Ipilimumab (IPI) in metastatic castrate-resistant prostate cancer (mCRPC): Results from an open-label, multicenter phase I/II study.
S. Slovin, O. Hamid, S. Tejwani, C. Higano +7 more
2012Journal of Clinical Oncology0 citations
Semantic Scholar
5-Fluorouracil—induced cardiotoxicity: hints for predicting patients at risk
S. Tejwani
20090 citations
Semantic Scholar
Stress management in breast cancer patients by healing breath program.
G. Kamboj, S. Tejwani, P. Nangia-Makker, N. Oja‐Tebbe
2004Journal of Clinical Oncology0 citations
Semantic Scholar
Stress management in breast cancer patients by healing breath program
G. Kamboj, S. Tejwani, P. Nangia-Makker, N. Oja‐Tebbe
20040 citations
Semantic Scholar
E=MC2: a new formula for improving the prostate cancer patient’s care experience
M. Gabel, D. McEvoy, C. Fleming, S. Tejwani +7 more
20020 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Slovin×5
Invite
S. Slovin — researcher profile on SciRah
C. Higano×5
Invite
C. Higano — researcher profile on SciRah
T. Beer×5
Invite
T. Beer — researcher profile on SciRah
A. Harzstark×4
Invite
A. Harzstark — researcher profile on SciRah

×4

Invite

H. Scher — researcher profile on SciRah

Invite

M. Menon — researcher profile on SciRah

Invite

J. Alumkal — researcher profile on SciRah

Invite

K. Chin — researcher profile on SciRah

Invite

P. Gagnier — researcher profile on SciRah

M. B. McHenry×3

Invite

M. B. McHenry — researcher profile on SciRah

Invite

O. Hamid — researcher profile on SciRah

U. Vaishampayan×3

Invite

U. Vaishampayan — researcher profile on SciRah